Breast Cancer Publications


Selected Publications Jun - Dec 2016


  1. Considerations regarding lipofilling in patients after breast cancer. J Plast Reconstr Aesthet Surg. 2016 May; 69(5):e103-4. Chan CW.
  2. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus. Breast Cancer Res. 2016 Jun 21; 18(1):64. Zeng C, … Hartman M, … Zheng W et al.
  3. HIFI-α activation underlies a functional switch in the paradoxical role of Ezh2/PRC2 in breast cancer. Proc Natl Acad Sci USA. 2016 Jun 28; 113(26):E3735-44. Mahara S, Lee PL, Feng M, Tergaonkar V, Chng WJ, Yu Q.
  4. Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Oncol. 2016 June. Krop IE, Mayer IA, Ganju V, Dickler M, Johnston S, Morales S, Yardley DA, Melichar B, Forero-Torres A, Lee SC, de Boer R, Petrakova K, Vallentin S, Perez EA, Piccart M, Ellis M, Winer E, Gendreau S, Derynck M, Lackner M, Levy G, Qiu J, He J, Schmid P.
  5. An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression. Hum Mol Genet. 2016 Jul 11. Wyszynski A, … Hartman M, … Cole MD et al.
  6. High expression of intratumoral stromal proteins is associated with chemotherapy resistance in breast cancer. Oncotarget. 2016 Jul 28. Wang T, Srivastava S, Hartman MBuhari SAChan CWIau P, Khin LW, Wong A, Tan SHGoh BCLee SC.
  7. Genome-wide meta-analyses of breast, ovarian, and prostate cancer association studies identify multiple new susceptibility loci shared by at least two cancer types. Cancer Discov. 2016 Jul; 6(9):1052-67. Kar SP, ... Lee SC, ...Lambrechts D et al.
  8. Manganese superoxide dismutase expression regulates the switch between an epithelial and a mesenchymal-like phenotype in breast carcinoma. Antioxid Redox Signal. 2016 Aug 20; 25(6):283-99. Loo SY, Hirpara JL, Pandey V, Tan TZ, Yap CT, Lobie PE, Thiery JP, Goh BC, Pervaiz S, Clément MV, Kumar AP.
  9. Fine-mapping of the 1p11.2 breast cancer susceptibility locus. PLoS One. 2016 Aug 24; 11(8):e0160316. Horne HN, … Hartman M, … Figueroa JD.
  10. Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancer. Oncotarget. 2016 Aug 25. Wong AL, Sundar R, Wang TT, Ng TC, Zhang B, Tan SHSoh TPang A, Tan CS, Ow S, Wang L, Mogro J, Ho JSJeyasekharan ADHuang YQ, Thng CH, Chan CWHartman MIau PBuhari SAGoh BCLee SC.
  11. Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs). Sci Rep. 2016 Sep 7 ;6:32512. Darabi H, … Hartman M, … Lee SC, ... Dunning AM et al.
  12. Accelerated partial breast irradiation in an Asian population: dosimetric findings and preliminary results of a multicatheter interstitial program. Onco Targets Ther. 2016 Sep 8; 9:5561-6. Koh YV, Tan PW, Buhari SAIau PChan CW, Shen L, Tan SHTang JI.
  13. Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer. Int J Cancer. 2016 Sep 15; 139(6):1303-17. Shi J, … Hartman M, … Long J et al.
  14. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation. Am J Hum Genet. 2016 Oct 6; 99(4):903-911. Ghoussaini M, … Hartman M, … Edwards SL et al.
  15. The impact of in situ breast cancer and family history on risk of subsequent breast cancer events and mortality - a population-based study from Sweden. Breast Cancer Res. 2016 Oct 18; 18(1):105. Sackey H, Hui M, Czene K, Verkooijen H, Edgren G, Frisell J, Hartman M.
  16. Significant Effect of Polymorphisms in CYP2D6 on Response to Tamoxifen Therapy for Breast Cancer; a Prospective Multicenter Study. Clin Cancer Res. 2016 Oct 19. Zembutsu H, …, Hartman MChan CW, …, Nakamura Y.
  17. Validation of the CancerMath prognostic tool for breast cancer in Southeast Asia. BMC Cancer. 2016 Oct 21; 16(1):820. Miao H, Hartman M, Verkooijen HM, Taib NA, Wong HS, Subramaniam S, Yip CH, Tan EY, Chan P, Lee SC, Bhoo-Pathy N.